Average Co-Inventor Count = 5.08
ph-index = 14
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Fibrogen, Inc. (37 from 89 patents)
2. Min Wu (0 patent)
3. Michael P. Arend (0 patent)
4. Eric D. Turtle (0 patent)
5. Heng Cheng (0 patent)
6. Lee A. Flippin (0 patent)
7. Wen-bin Ho (0 patent)
8. Shaojiang Deng (0 patent)
37 patents:
1. 11680047 - Enhanced erythropoiesis and iron metabolism
2. 11229637 - Nitrogen-containing heteroaryl compounds and methods of use thereof
3. 10927081 - Enhanced erythropoiesis and iron metabolism
4. 10646482 - Nitrogen-containing heteroaryl compounds and methods of use thereof
5. 10272078 - Crystalline forms of a prolyl hydroxylase inhibitor
6. 10118897 - Crystalline forms of a prolyl hydroxylase inhibitor
7. 10092558 - Nitrogen-containing heteroaryl compounds and methods of use thereof
8. 9918977 - Crystalline forms of a prolyl hydroxylase inhibitor
9. 9708269 - Process for making isoquinoline compounds
10. 9695170 - Naphthyridine derivatives as inhibitors of Hypoxia inducible factor (HIF) hydroxylase
11. 9643928 - Crystalline forms of {[1-cyano-5-(4-chlorophenoxy)-4-hydroxy-isoquinoline-3-carbonyl]-amino}-acetic acid
12. 9617218 - Crystalline forms of a prolyl hydroxylase inhibitor
13. 9409892 - 4-hydroxy-isoquinoline compounds as HIF hydroxylase inhibitors
14. 9387200 - Isothiazole-pyridine derivatives as modulators of HIF (hypoxia inducible factor) activity
15. 9371288 - Crystalline forms of a prolyl hydroxylase inhibitor